Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.54 |
| ▸ | EGFR | P00533 | 2/20 | 0.51 |
| ▸ | IGF1R | P08069 | 3/20 | 0.51 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.50 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.48 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.48 |
| ▸ | LCK | P06239 | 2/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | MTOR | P42345 | 2/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.43 |
| ▸ | RGS12 | O14924 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5848701 | 1.00 | TRPA1 (0.57) | TRPA1PTPN1EGFRIGF1RPRMT1 | |
| SCHEMBL8089211 | 0.85 | TRPA1 (0.74) | TRPA1PTPN1PRMT1PTPN2PTPN6 | |
| SCHEMBL8089207 | 0.85 | TRPA1 (0.74) | TRPA1PTPN1PRMT1PTPN2PTPN6 | |
| SCHEMBL4608757 | 0.84 | PTGS2 (0.54) | PTPN1EGFRLCKPTGS2NPC1 | |
| SCHEMBL4608754 | 0.84 | PTGS2 (0.54) | PTPN1EGFRLCKPTGS2NPC1 | |
| SCHEMBL30928258 | 0.81 | PRMT1 (0.75) | TRPA1PTPN1EGFRIGF1RPRMT1 | |
| SCHEMBL28392399 | 0.80 | AKR1C3 (0.69) | PTPN1EGFRIGF1RPRMT1PTPN2 | |
| SCHEMBL29396510 | 0.79 | EGFR (0.50) | TRPA1PTPN1EGFRPRMT1PTGS2 | |
| SCHEMBL1005213 | 0.79 | EGFR (0.50) | TRPA1PTPN1EGFRPRMT1PTGS2 | |
| SCHEMBL31185735 | 0.76 | TRPA1 (0.63) | TRPA1PTPN1PRMT1PTPN2PTPN6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7026518-B2 | Resveratrol analogs | LAILA IMPEX (IN) | 2006-04-11 | — | — | US | claimed |
| US-20040209951-A1 | Novel resveratrol analogs | LAILA IMPEX (IN) | 2004-10-21 | — | — | US | claimed |
| US-7026518-B2 | Resveratrol analogs | LAILA IMPEX (IN) | 2006-04-11 | — | — | US | disclosed |
| US-20040209951-A1 | Novel resveratrol analogs | LAILA IMPEX (IN) | 2004-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040209951-A1 | Novel resveratrol analogs | HRH1, CBR1, CBR3 | TRPA1 1863/4885PTPN1 1566/4885EGFR 3929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.